Irinotecan

Collect

BASIC PARAMETERS Find an error

CAS: 97682-44-5
MF: C33H38N4O6
MW: 586.67802
Synonyms: Irinotecan

REPORT BY

Li Zhang

Chinese Academy of Science
follow

Yu Liu

Nankai University
follow

Li Wang

Jilin University
follow

Bo Liu

The University of Science and Technology of China
follow

Min Chen

Zhejiang University
follow

Li Zhang

Sun Yat-sen University
follow

Wei Huang

Shanghai Jiao Tong University
follow
Co-reporter: Ping Huang, Junping Ao, Linzhu Zhou, Yue Su, Wei Huang, Xinyuan Zhu, and Deyue Yan
pp: 1564
Publication Date(Web):May 20, 2016
DOI: 10.1021/acs.bioconjchem.6b00158
Drug combinations have been widely used in cancer treatment. However, it remains a formidable challenge to deliver three or more therapeutic agents in one nanoparticle with a precise and tunable molar ratio because of differences in pharmacokinetics and biodistribution of various anticancer drugs. Herein, we reported a facile approach to construct ternary cocktail nanoparticles, which are composed of three different anticancer drugs, such as gemcitabine, chlorambucil, and irinotecan, through the molecular coassembly of two amphiphilic drug–drug conjugates. The component of these nanoparticles can be simply adjusted by changing the feed ratio of two amphiphilic drug–drug conjugates in the coassembly process. Without the help of any drug carriers, they can self-deliver, release three drugs synchronally, and obtain the optimal synergistic therapeutic effect. This facile strategy may open a new way for cancer combination therapy.

Deyue Yan

Shanghai Jiao Tong University
follow

Yongfeng Zhou

Shanghai Jiao Tong University
follow

Xinyuan Zhu

Shanghai Jiao Tong University
follow